590 / 1498
PFS by induction regimen
R-CVP versus R-CHOP versus R-FM as first-line therapy for advanced-
stage follicular lymphoma: Final results of FOLL05 trial from the
Fondazione Italiana Linfomi (FIL).Federico et al
J Clin Oncol 2013
R-CHOP 66.5% (63.1–69.6%)
R-FCM 58.9% (43.0–71.8%)
R-CVP 48.9% (42.4–55.0%)
100
80
60
40
20
0
Patients (%)
0
1
2
3
4
5
Time (years)
42 months
R-CHOP n = 881
R-CVP n = 268
R-FCM n = 44
p
< 0.0001